The Ministry of Health of Russia approved the first drug against Covid-19. The relevant information appeared on the State Registry of Medicines.
“The trade name of the drug is Avifavir. The international non-proprietary or grouping or chemical name is Favipiravir,” the document reads.
In March, RDIF created a joint venture with the KhimRar company for the production of Favipiravir. A month ago, their joint venture entered the stage of clinical trials, which ended yesterday.
